A controversial pharmaceutical company that makes a highly addictive opioid donated $500,000 to a campaign fighting a ballot measure in Arizona that would legalize recreational marijuana. Marijuana is a cheaper and safer alternative to drugs that the likes of Insys sell, the advocates argue. The drop was “attributable” to a 27.7 percent decrease in Subsys sales, which the company partly offset through price increases. The accusations are particularly problematic, because of the risks associated with the abuse of fentanyl-based drugs like Subsys. (Purdue’s aggressive marketing of OxyContin is blamed for enabling the overprescription and abuse that gave rise to the current opioid crisis.)

Source: Huffington Post September 10, 2016 20:37 UTC